Sigma Cure 7621M UCB Pt2

HA International, LLC

Revision date : 2011-02-15

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

9016-87-9

Name of the chemical

4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)

Concentration

30.0-50.0

EC/CAS

101-68-8

Name of the chemical

4,4’-Methylenediphenyl diisocyanate

Concentration

10.0-30.0

EC/CAS

26447-40-5

Name of the chemical

Methylenediphenyl diisocyanate (see also specific isomers)

Concentration

5.0-10.0

EC/CAS

8008-20-6

Name of the chemical

Kerosine (petroleum)

Concentration

1.0-5.0

Listed in

EC/CAS

64742-81-0

Name of the chemical

Kerosine (petroleum), hydrodesulfurized

Concentration

1.0-5.0

Listed in

EC/CAS

91-20-3

Name of the chemical

Naphthalene,3

Concentration

0.1-1.0

General Information

Revision date

2011-02-15

Product name

Sigma Cure 7621M UCB Pt2

1.2.1 Relevant identified uses

Foundry Core and Mold/Mould Applications - Part 2

supplier name

630 Oakmont Lane

Emergency telephone

1-866-303-6949, (800) 424-9300, (703) 527-3887

Icons in SDS

M004 M009 M010 M011 M017

Company Information

company name

HA International, LLC

GHS Information

Signal word

WARNING

Section 2

SECTION 2: Hazards identification

(29 CFR 1910.1200) Form Liquid

Potential Acute Health Effects

Inhalation Can cause central nervous system (CNS) depression. Irritating to respiratory system. May cause sensitization by inhalation. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Harmful by inhalation. Repeated exposure or a single large exposure may cause isocyanate sensitization (chemical asthma). Once sensitized, individuals may react to a later exposure at levels well below the applicable exposure limits. These symptoms could be immediate or delayed up to several hours after exposure. There are reports that once sensitized, symptoms may occur upon exposure to dust, cold air or other irritants. Sensitization can either be temporary or permanent. Ingestion Can cause central nervous system (CNS) depression. Skin Irritating to skin. May cause sensitization by skin contact. Skin contact may trigger respiratory sensitization and symptoms of allergic response including airway restriction, inflammation of airway tissues, and breathing difficulty. Isocyanates react with skin protein and moisture and can cause irritation and skin staining. Cured material is difficult to remove. Eyes Irritating to eyes. Potential chronic health effects

Potential chronic health

Contains material that can cause target organ damage. Chronic overexposure to isocyanates has also been reported to cause lung damage (including fibrosis, decrease in lung function) which may be permanent. Preexisting asthma and other respiratory disorders (bronchitis, emphysema, hyperreactivity) may be aggravated by exposure. Carcinogenicity Contains material which may cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: kidneys, lungs, liver, central nervous system (CNS), Review Section 2 and 11 for any additional assessments. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: nausea or vomiting, respiratory tract irritation, coughing, headache, drowsiness/fatigue, dizziness/vertigo, wheezing and breathing difficulties, unconsciousness, asthma, chest tightness or wheezing, breathing difficulty or shortness of breath asthmatic attack, Ingestion Adverse symptoms may include the following: nausea or vomiting, dizziness/vertigo, drowsiness/fatigue, headache, unconsciousness, Skin Adverse symptoms may include the following: irritation, redness, Eyes Adverse symptoms may include the following: pain or irritation, watering, redness, Medical conditions aggravated by over-exposure Pre-existing respiratory and skin disorders and disorders involving any other target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. See section 11 for more detailed information on health effects and symptoms.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.